All In Biotech

Drug Trial Radar · NCT07935889

Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 Trial

Stereotactic Advanced-Imaging Guided Radiotherapy for Glioblastoma (SAGA 2.0)

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 292 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

292

Planned (sponsor's estimate)

Start

Nov 13, 2026

Primary completion

Nov 30, 2035

Study completion Nov 30, 2035

Sponsor

Lead sponsor
Mayo ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 13, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial studies how well advanced imaging-guided standard dose versus (vs.) dose-intensified radiation therapy (RT) and dose-intensified accelerated RT works in treating patients with newly diagnosed glioblastoma. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill tumor cells and shrink tumors. During dose-intensified RT, a higher dose than normal of radiation therapy is delivered over 6 weeks. During dose-intensified accelerated RT, the higher dose of radiation therapy is delivered over a shorter amount of time (2 weeks) than normal (6 weeks). Patients also undergo an advanced brain imaging positron emission tomography (PET)/computed tomography (CT) scan (using a radioactive drug called either FET or FDOPA) prior to RT to that may help doctors better plan the treatment. Dose-intensified and dose-intensified accelerated radiation therapy may be effective in treating patients with newly diagnosed glioblastoma. Giving dose-intensified RT or dose-intensified accelerated RT guided by advanced imaging may work better than standard dose RT in treating patients with newly diagnosed glioblastoma. IND Numbers: 61300, 140882, 176402, 154793, 167879

Conditions

  • Glioblastoma, IDH-Wildtype

Interventions

  • Biospecimen CollectionProcedure

    Undergo blood sample collection

  • Computed TomographyProcedure

    Undergo FET or FDOPA PET/CT

  • F-18 FluoroethyltyrosineRadiation

    Given via injection

  • Fluorodopa F 18Drug

    Given IV

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • Dose-intensified Photon Beam Radiation TherapyRadiation

    Undergo dose-intensified photon radiation therapy

  • Standard Photon Beam Radiation TherapyRadiation

    Undergo standard photon radiation therapy

  • Dose-intensified Accelerated Photon Beam Radiation TherapyRadiation

    Undergo dose-intensified accelerated photon radiation therapy

  • Accelerated Photon Beam Radiation TherapyRadiation

    Undergo accelerated photon radiation therapy

  • Positron Emission TomographyProcedure

    Undergo FET or FDOPA PET/CT

  • Proton Beam Radiation TherapyRadiation

    Undergo dose-intensified proton radiation therapy

  • Proton Beam Radiation TherapyRadiation

    Undergo standard proton radiation therapy

  • Proton Beam Radiation TherapyRadiation

    Undergo dose-intensified accelerated proton radiation therapy

  • Proton Beam Radiation TherapyRadiation

    Undergo accelerated proton radiation therapy

  • Questionnaire AdministrationOther

    Ancillary studies

  • TemozolomideDrug

    Given SOC temozolomide

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall survival (Cohort 1)Time frame: Up to 18 months
  2. Overall survival (Cohort 2)Time frame: Up to 12 months

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic in Arizona

    Scottsdale, Arizona · Not yet recruiting

  • Mayo Clinic in Florida

    Jacksonville, Florida · Not yet recruiting

  • Mayo Clinic Health System in Albert Lea

    Albert Lea, Minnesota · Recruiting

  • Mayo Clinic Health Systems-Mankato

    Mankato, Minnesota · Recruiting

  • Mayo Clinic Radiation Therapy - Northfield

    Northfield, Minnesota · Recruiting

  • Mayo Clinic in Rochester

    Rochester, Minnesota · Recruiting

  • Mayo Clinic Health System-Eau Claire Clinic

    Eau Claire, Wisconsin · Recruiting

  • Mayo Clinic Health System-Franciscan Healthcare

    La Crosse, Wisconsin · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.